These include musculoskeletal abnormalities and elevated CK levels in the patient with CGL4 (Case 3), while the early onset progression of steatosis to cirrhosis in a patient with CGL2 (Case 1) lends support for the rapid development of liver disease in this CGL subtype (30, 50, 65). The gene discussed is GZMH; the disease is steatosis.